{
  "ticker": "LLY",
  "analysis_asof": "2026-04-17T03:28:04.258685+09:00",
  "market_data_asof": "2026-04-16",
  "level_basis": "daily_close",
  "thesis_state": "constructive",
  "primary_setup": "watch_only",
  "portfolio_stance": "BULLISH",
  "entry_action_base": "WAIT",
  "setup_quality": "DEVELOPING",
  "confidence": 0.68,
  "action_if_triggered": "NONE",
  "starter_fraction_of_target": null,
  "breakout_level": null,
  "breakout_confirmation": "close_above",
  "pullback_buy_zone": null,
  "invalid_if_close_below": null,
  "invalid_if_intraday_below": null,
  "min_relative_volume": 1.0,
  "session_vwap_preference": "indifferent",
  "event_guard": {
    "earnings_date": null,
    "block_new_position_within_days": 0,
    "allow_add_only_after_event": false,
    "requires_post_event_rerun": false
  },
  "reason_codes": [
    "trigger:902-905_위에서_일간_종가_방어가_반복되고_거래량이_안정되는지_확인:_이_조건_충족_시_제한적_star",
    "trigger:925-926_종가_회복:_10일_ema_924.68과_vwma_925.86_회복으로_1차_진입_조건_확인",
    "trigger:rsi_50_회복과_macd의_양호한_개선:_과매도_반등에서_추세_회복으로_전환되는지_확인",
    "trigger:955_돌파:_200일선_방어_이후_반등_신뢰도_강화_및_추가_매수_검토",
    "trigger:976-977_회복:_50일선_976.87_회복으로_중기_추세_복구와_본격_overweight_확대_검토",
    "trigger:902_아래_고거래량_종가:_신규_매수_중단_및_877-878_지지_재시험_경보"
  ],
  "notes": [
    "catalyst:q1_결과에서_mounjaro와_zepbound_매출_가속,_마진_유지,_eps_성장_지속이_확인되는_경우",
    "catalyst:공급_확대,_재고_13.744b,_건설중인_자산_13.013b,_capex가_실제_sell-through와_",
    "catalyst:foundayo_후속_자료나_fda_소통에서_안전성,_label,_post-marketing_요구가_상업성을",
    "catalyst:925-926_회복_후_955_돌파,_rsi_50_회복,_macd_개선이_동반되는_기술적_회복",
    "catalyst:centessa,_crossbridge_bio,_ac_immune_관련_파이프라인_다각화가_glp-1_의존도",
    "catalyst:추가_애널리스트_목표가_상향_또는_추정치_상향이_glp-1_수요와_마진_내구성을_반영하는_경우"
  ]
}